US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist
  • 5.655
  • +0.445+8.54%
Close Nov 29 13:00 ET
  • 5.655
  • 0.0000.00%
Post 13:02 ET
241.81MMarket Cap-10098P/E (TTM)

About DiaMedica Therapeutics Company

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Company Profile

SymbolDMAC
Company NameDiaMedica Therapeutics
Listing DateDec 7, 2018
Issue Price4.00
Founded2000
CEOMr. Rick Pauls
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address301 Carlson Parkway,Suite 210
CityMinneapolis
ProvinceMinnesota
CountryUnited States of America
Zip Code55305
Phone1-763-496-5454

Company Executives

  • Name
  • Position
  • Salary
  • Rick Pauls
  • Director, President and Chief Executive Officer
  • 1.22M
  • Scott Kellen
  • Chief Financial Officer, Principal Accounting Officer and Secretary
  • 632.22K
  • Dominic R. Cundari
  • Chief Commercial Officer
  • --
  • Lorianne Masuoka
  • Chief Medical Officer
  • --
  • David J. Wambeke
  • Chief Business Officer
  • --
  • Lorianne Musuoka
  • Chief Medical Officer
  • --
  • Rebekah de Vitry Fries
  • Vice President of Clinical Operations
  • --
  • Julie VanOrsdel Daves
  • Senior Vice President, Clinical Development Operations
  • 533.37K
  • Richard D. Pilnik
  • Chairman of the Board
  • 133.98K
  • Tanya Lewis, M.S.
  • Independent Director
  • 91.85K
  • Dr. Richard E. Kuntz, M.D.,M.Sc.
  • Independent Director
  • 96.02K
  • James T. Parsons
  • Independent Director
  • 97.18K
  • Charles Semba, M.D.
  • Independent Director
  • 89.68K
  • Dr. Michael Giuffre, M.D.
  • Independent Director
  • 90.93K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data